Visit thePulmonary Fibrosis Newsforums to connect with others in the PF community. View Forums Perspectives Go to previous slide Go to next slide December 17, 2024ColumnsbySamuel Kirton Ways to handle the isolation that can come with the holidays ...
Pulmonary Fibrosis News ForumsWelcome Lounge This forum is welcome to all members of the PF/IPF community. Topics will primarily be applicable to patients,… Using Our Forums 3 days, 14 hours ago PF Communities This is for various subgroups of the PF community (patients, caregivers, family...
Health Tip:Living with Pulmonary Fibrosis Feb. 14, 2018 Male Triathletes May Be Harming Their Hearts Nov. 21, 2017 Cocaine-Related Heart Damage May Be 'Silen Study of people addicted to drug finds structural harm in 83% June 22, 2011 Galleries America 2024 The Best Political Cartoons on Joe...
Fattman, Cheryl L
Good And Bad News For Patients With Pulmonary Fibrosis Following Genetic DiscoveryTeresa Barnes
and Drug Administration Patients With Cystic Fibrosis Have New Triple-Drug Combination Rebecca Voelker, MSJ JAMA Medical News & Perspectives Cystic Fibrosis Affects People of All Colors, Not Just Those Who Are White Rita Rubin, MA JAMA JAMA Patient Page Patient Information: Cystic Fibrosis ...
A recent study from China has reported that Cordyceps sinensis (CS), a traditional Chinese medicinal fungus, can ameliorate idiopathic pulmonary fibrosis (IPF)
2022 Clinical Trial of Buyang Huanwutang in Treatment of Connective Tissue Disease-associated Pulmonary Fibrosis with Syndrome of Qi Deficiency and Blood Stasis Chinese Journal of Experimental Traditional Medical Formulae, 2022 Syndrome and Treatment Rules of Traditional Chinese Medicine in Treating Chronic...
γδT Cell-derived interleukin-17A via an interleukin-1β-dependent mechanism mediates cardiac injury and fibrosis in hypertension. Hypertension. 2014;64(2):305–14. Article CAS PubMed Google Scholar Nguyen H, Chiasson VL, Chatterjee P, Kopriva SE, Young KJ, Mitchell BM. Interleukin-17 ...
post-COVID ILD; COVID-19; interstitial lung disease; residual lung abnormalities; pulmonary fibrosis1. Introduction On 31 December 2019, the World Health Organization (WHO) recognized cases of ‘viral pneumonia’ in Wuhan, China, which was later identified as SARS-CoV-2 [1]. By 11 March ...